ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ETX E-therapeutics Plc

9.00
0.00 (0.00%)
14 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
E-therapeutics Plc LSE:ETX London Ordinary Share GB00B2823H99 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 9.00 9.00 9.50 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 475k -8.27M -0.0142 -6.34 52.55M
E-therapeutics Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker ETX. The last closing price for E-therapeutics was 9p. Over the last year, E-therapeutics shares have traded in a share price range of 8.00p to 24.00p.

E-therapeutics currently has 583,844,162 shares in issue. The market capitalisation of E-therapeutics is £52.55 million. E-therapeutics has a price to earnings ratio (PE ratio) of -6.34.

E-therapeutics Share Discussion Threads

Showing 1401 to 1422 of 2200 messages
Chat Pages: Latest  64  63  62  61  60  59  58  57  56  55  54  53  Older
DateSubjectAuthorDiscuss
23/3/2020
08:40
They MUST be speaking to government as the suggestion and POTENTIAL is significant.

Surprised this strategy has not been executed before now - a little disappointing.

red army
23/3/2020
08:30
Well, the RNS is bold and proactive.... Just what is needed in these uncertain times...

GLA

paulcon1
23/3/2020
08:16
Very difficult to buy now.
matt123d
23/3/2020
07:04
Well..this could be interesting!
dplewis1
22/3/2020
10:56
Yes, following on Twitter. Good to have a CEO who's familiar with financial markets and the timing of them.
matt123d
19/3/2020
15:26
I'm hopeful of news because he said they were in late stage discussions with a number of exciting potential collaborations so presumably sign offs could happen imminently/within weeks

Also he seems to fancy himself as a trader so I think he'll try to release news into a postive rebounding market. He was calling bottom a few days ago. Seemed to be warming up to markets turning as well.

I have high hopes.

the stigologist
19/3/2020
15:13
He's probably just taking a break from markets / talking to mentalists on twitter.. not sure his silence would be the forbear of news. Possibly a bit of post hoc fallacy creeping in there stig ;)
dplewis1
19/3/2020
15:06
hmm Ali is a bit quiet on twitter today
news incoming ?
I'd take either of AZN or GSK

the stigologist
18/3/2020
16:17
Equally works as message to ETX shareholders
the stigologist
17/3/2020
22:13
GSK and AZN look like favourites...
the stigologist
17/3/2020
19:51
"an important inflection point"

www.proactiveinvestors.co.uk/companies/news/915087/e-therapeutics--at-an-important-inflexion-point--915087.html

the stigologist
17/3/2020
14:33
"late stage discussions...number of exciting potential collaborations"

if they announce Astra Zeneca or GSK Glaxo deal we all know this will go nuts

the stigologist
17/3/2020
10:15
This Coronavirus epidemic is demonstrating the need for social distancing and Work-From-Home solutions which is an ideal environment for vendors of Computational Biology/AI/ML solutions

One would imagine any potential clients and partners are taking ETX et al a whole lot more seriously now than they ever were a few weeks back. AI/ML/Computational Biology capabilities have gone from being 'nice to haves' to 'must haves'.

Furthermore one would imagine the UK Government and Investors realising the need of the hour will be looking to invest seriously in this industry and of course it will be leaders like ETX who are best placed to scoop up any of that capital looking for a home.

the stigologist
17/3/2020
09:04
Cash is brilliant

Almost 2 years runway even before the £1.6m raised in Friends and Family raise


-- Revenues of GBP0.5m (FY19: GBP0.04m)
-- Cash at 31 January 2020 of GBP3.8m (FY19: GBP5.9m)
-- Cash reduction in the year of GBP2.1m (FY19: GBP3.7m)

the stigologist
17/3/2020
08:23
If you don't find that statement exciting you need your head checked.

Have you not read it?
Don't comprehend it?

It's revolutionary. Mortazavi telling you he had access to the 'data room' when he did his Due Diligence.

There is serious interest from Industry.

He wants to make it big.

1000% increase in Revenue (admittedly from low base) but look at quality and validation that revenue increase gives.

I guess what you mean by not exciting is they didn't headline it "multi million $ deals incoming from Big Pharma/GSK/AZN"

the stigologist
17/3/2020
07:25
Yep, nothing too exciting really. At least they have a decent amount of cash. Wouldn't fancy having to raise funds in this environment
dplewis1
16/3/2020
20:10
I don't think anybody expects Rome to be built in a day

This Coronavirus epidemic is demonstrating the need for social distancing and Work-From-Home solutions which is an ideal environment for vendors of Computational Biology/AI/ML solutions

One would imagine any potential clients and partners are taking ETX et al a whole lot more seriously now than they ever were a few weeks back. AI/ML/Computational Biology capabilities have gone from being 'nice to haves' to 'must haves'.

Furthermore one would imagine the UK Government and Investors realising the need of the hour will be looking to invest seriously in this industry and of course it will be leaders like ETX who are best placed to scoop up any of that capital looking for a home.

the stigologist
16/3/2020
18:18
Results tomorrow. Not an ideal time to be putting numbers out unless they are bullet proof.. at least they have decent cash but needs some positive noises around contracts etc
dplewis1
13/3/2020
23:25
The cure for corona will be cheap or free and not commercially lucrative.

Which bio company got rich off Ebola or SARS or MRSA cures?

The overall pharmaceutical market is worth hundreds of billions

Providing their platform tech to just one big Pharma will be worth potentially hundreds of millions (eg Exscientia deal with Bayer £240m)

Get one of their own drugs thru trials alone or in partnership it becomes a Billion + Biotech/Pharma company

the stigologist
13/3/2020
22:35
Ali is a smart bloke but nobody can call the bottom especially with so much potential bad news to come. Now if he could just get ETX to come up with a cure for corona that would be genuinely useful..
dplewis1
13/3/2020
22:34
Market liked it!
matt123d
13/3/2020
22:07
I don't think so, just watched Trump speech on the TV !!! SO BAD !!
parsons4
Chat Pages: Latest  64  63  62  61  60  59  58  57  56  55  54  53  Older

Your Recent History

Delayed Upgrade Clock